| abstract |
The invention relates to regulatory T-cells containing galectins, in particular, the use thereof as markers and for the therapy and diagnosis of diseases, in particular, of allergies and autoimmune diseases, in particular, rheumatoid arthritis, multiple sclerosis or Crohn's disease, chronic inflammation, asthma, immune-deficiency diseases, AIDS, transplant rejection, cancer diseases and diabetes. |